Entropy Technologies’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
+5,779
New +$1.13M 0.05% 460
2026
Q1
Sell
-11,380
Closed -$1.97M 950
2025
Q4
$1.97M Buy
+11,380
New +$2.07M 0.11% 246
2024
Q3
Sell
-1,730
Closed -$237K 774
2024
Q2
$237K Sell
1,730
-1,865
-52% -$255K 0.03% 562
2024
Q1
$479K Sell
3,595
-2,643
-42% -$343K 0.05% 456
2023
Q4
$860K Buy
+6,238
New +$820K 0.16% 223

Other funds holding DGX

Entropy Technologies's DGX Position: Q2 2026 in Review

Entropy Technologies opened a new position in Quest Diagnostics (DGX) in Q2 2026: 5,779 shares worth $1.22M. The stake represents 0.05% of the portfolio and ranks #460 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in DGX as recently as Q4 2025.

Entropy Technologies first reported a position in DGX in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.97M in Q4 2025. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Entropy Technologies held 5,779 shares of Quest Diagnostics worth $1.22M as of Q2 2026.
  • Quest Diagnostics was a new Entropy Technologies position in Q2 2026.
  • Quest Diagnostics made up 0.05% of Entropy Technologies's portfolio in Q2 2026, its #460 holding.
  • Entropy Technologies first reported a position in Quest Diagnostics in Q4 2023 and has held it in 5 quarters since.
  • Entropy Technologies's Quest Diagnostics position peaked at $1.97M in Q4 2025.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.